Discover · art19.com

Rapid Response: Riding the Ozempic wave, w/RO's CEO Zach Reitano

Masters of Scale art19.com

This is what was read here when it was published. art19.com no longer carries it in what it publishes now.

Rabid demand for weight-loss drugs like Ozempic and Wegovy is altering US society and transforming the healthcare industry. Rapid Response host Bob Safian guides us through the upheaval and lessons, talking with CEO Zach Reitano of Ro, a telehealth platform that has ridden the wave to a $7 billion valuation. Reitano shares why he chose obesity-treatment as his company’s “hero product,” the impact of weight-loss drugs on industries beyond health-care, and why the potential of GLP-1s like Ozempic mirrors that of AI.

Read a transcript of this episode: https://mastersofscale.com

  • Listed at $7
More ways to use this
Open on another device
Scan this QR code to open the same public page

Scan to open this page. Your saved notes and account access are not included.

Download QR code

Open the page link

Keep going

Each of these is read from what this estate already kept: the feed a piece came through, the publisher behind it, the credits and topics the publisher printed. None of it is a recommendation, an identity or a record kept anywhere else.

Also from Masters of Scale

  1. Replit’s $9B perfect storm, and the winds of “AI psychosis,” with Amjad MasadListed at $9 art19.com
  2. The “best practices” corrupting business, with Eric Ries and Krista Tippettart19.com
  3. Inside Walmart’s biggest shake-up in years, w/ CEO John Furnerart19.com
  4. From underdogs to disruptors: how Tubi and e.l.f. built a different gameart19.com
  5. Open to Debate: should we trust AI agents with our information?art19.com
  6. Demis Hassabis says society is “not ready” for the AI futureart19.com